Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and tolerability of TransCon IL-2 β/γ alone or in combination w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MK-6070 (HPN328-4001), a DLL3-targeted therapy, in advanced cancers expressing DLL3, including small c…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
A real-world French study evaluating how durvalumab is used and its effectiveness as first-line therapy for extensive-stage small cell lung …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment [Phase 2]
Phase 2 trial evaluating safety and efficacy of Tarlatamab with etoposide, carboplatin, and atezolizumab in transformed small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Tasca Therapeutics is testing CP-383 in a Phase 1/2 trial for patients with advanced or metastatic solid tumors, including colorectal cancer…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC [Phase 1]
A Phase I study to evaluate the safety, tolerability, and pharmacokinetics of HLX3901 in patients with advanced small cell lung cancer or ne…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating adjuvant chemotherapy and immunotherapy after complete surgical resection in small …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating alisertib in extensive-stage small cell lung cancer is currently recruiting. The sponsor is Puma Biotechnology.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of BL0020 injection for small cell lung cancer transformed from non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment [Phase 1]
Phase I study evaluating the safety and preliminary efficacy of Actinium-225 DOTATATE in combination with tislelizumab as maintenance therap…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer [Phase 3]
BioNTech's investigational therapy BNT327, in combination with chemotherapy, is being studied in untreated extensive-stage small-cell lung c…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of the triple combination niraparib, temozolomide, and atezolizumab in patients with …
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Sarcopenia and Cachexia in Patients With Lung Cancer
This clinical trial update indicates an ongoing study examining sarcopenia and cachexia in patients with lung cancer (both non-small cell an…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)
An update on a trial evaluating durvalumab after concurrent chemoradiotherapy in limited-stage small-cell lung cancer, with the study status…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain [Phase 2]
An ongoing Phase 2 clinical trial is evaluating stereotactic radiosurgery for patients with lung cancer that has spread to the brain and is …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Anlotinib in Cross-line Treatment of NSCLC and SCLC
This clinical trial update shows that anlotinib is being evaluated for cross-line treatment of advanced non-small cell lung cancer and exten…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study [Phase 2]
The document describes a Phase 2 exploratory study evaluating Adebrelimab plus oral etoposide in elderly or poor performance status patients…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) [Phase 2]
A multicenter Phase II randomized study evaluating adebrelimab in combination with chemotherapy and concurrent low-dose radiotherapy for ext…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors [Phase 2]
A Phase 2 study evaluating vobramitamab duocarmazine in metastatic castration-resistant prostate cancer and other solid tumors was terminate…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]
Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer [NA]
This entry reports a clinical trial evaluating YSQTG combined with immuno-chemotherapy for extensive-stage small cell lung cancer. The study…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC [Phase 2]
A Phase 2 trial is evaluating Niraparib in combination with anti-PD-L1 antibody maintenance for SLFN11-positive, extensive-stage small cell …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers [Phase 2]
A Phase 2 study (DAREON-5) is evaluating different doses of BI-764532 in people with small cell lung cancer and other neuroendocrine cancers…